Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Solid Tumor, Adult × Blood Specimen Collection × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Neoplasms 37 Breast Neoplasms 37 Lung Neoplasms 21 Colorectal Neoplasms 18 Carcinoma, Non-Small-Cell Lung 17 Prostatic Neoplasms 13 Uterine Cervical Neoplasms 10 Head and Neck Neoplasms 10 Pancreatic Neoplasms 9 Carcinoma, Hepatocellular 9 Sarcoma 8 Ovarian Neoplasms 8 Myelodysplastic Syndromes 8 Melanoma 8 Multiple Myeloma 7 Glioma 7 Colonic Neoplasms 7 Brain Neoplasms 7 Hematologic Neoplasms 6 Esophageal Neoplasms 6 Endometrial Neoplasms 6 Disease 6 Neoplastic Cells, Circulating 5 Leukemia, Myeloid, Acute 5 Leukemia 5 Gastrointestinal Neoplasms 5 Uveal Melanoma 4 Skin Neoplasms 4 Neoplasm, Residual 4 Lymphoma, Non-Hodgkin 4

Interventions

Proton Therapy 3 pembrolizumab 2 toripalimab 1 spartalizumab 1 pazopanib 1 patritumab deruxtecan 1 palbociclib 1 leronlimab 1 Valganciclovir 1 Radiotherapy 1 Paclitaxel 1 Lacteol 1 Interleukin-2 1 Docetaxel 1 Carboplatin 1 Blood Specimen Collection 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02220556 2025-08-08

CTC-CEC-ADN

Institut Curie

Phase NA Completed

Other solid neoplasm

Solid Tumor, Adult

Data powered by HemOnc (CC BY 4.0) Colophon ⚡